Correlation Between Lipocine and Azenta
Can any of the company-specific risk be diversified away by investing in both Lipocine and Azenta at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lipocine and Azenta into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lipocine and Azenta Inc, you can compare the effects of market volatilities on Lipocine and Azenta and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lipocine with a short position of Azenta. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lipocine and Azenta.
Diversification Opportunities for Lipocine and Azenta
Excellent diversification
The 3 months correlation between Lipocine and Azenta is -0.63. Overlapping area represents the amount of risk that can be diversified away by holding Lipocine and Azenta Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Azenta Inc and Lipocine is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lipocine are associated (or correlated) with Azenta. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Azenta Inc has no effect on the direction of Lipocine i.e., Lipocine and Azenta go up and down completely randomly.
Pair Corralation between Lipocine and Azenta
Given the investment horizon of 90 days Lipocine is expected to under-perform the Azenta. In addition to that, Lipocine is 1.71 times more volatile than Azenta Inc. It trades about -0.05 of its total potential returns per unit of risk. Azenta Inc is currently generating about 0.13 per unit of volatility. If you would invest 4,191 in Azenta Inc on August 28, 2024 and sell it today you would earn a total of 367.00 from holding Azenta Inc or generate 8.76% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Lipocine vs. Azenta Inc
Performance |
Timeline |
Lipocine |
Azenta Inc |
Lipocine and Azenta Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Lipocine and Azenta
The main advantage of trading using opposite Lipocine and Azenta positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lipocine position performs unexpectedly, Azenta can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Azenta will offset losses from the drop in Azenta's long position.Lipocine vs. Reviva Pharmaceuticals Holdings | Lipocine vs. ZyVersa Therapeutics | Lipocine vs. Unicycive Therapeutics | Lipocine vs. Checkpoint Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Other Complementary Tools
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
CEOs Directory Screen CEOs from public companies around the world |